Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | pivampicillin | 4260 | drug-path |
| Apoptosis | R-HSA-109581 | map04210 | pivampicillin | 4260 | drug-path |
| Basal transcription factors | R-HSA-3232118 | map03022 | pivampicillin | 4260 | drug-path |
| RNA polymerase | R-HSA-73864 | map03020 | pivampicillin | 4260 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | proguanil | 3242 | drug-path |
| Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | proguanil | 3242 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | proguanil | 3242 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | proguanil | 3242 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | proguanil | 3242 | drug-path |
| Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | proguanil | 3242 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | proguanil | 3242 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | proguanil | 3242 | drug-path |
| Chronic myeloid leukemia | R-HSA-9680350 | map05220 | proguanil | 3242 | drug-path |
| Glioma | Q9NZM4 | map05214 | proguanil | 3242 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | proguanil | 3242 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | proguanil | 3242 | drug-path |
| Pathways in cancer | R-HSA-9824443 | map05200 | proguanil | 3242 | drug-path |
| Insulin signaling pathway | R-HSA-74752 | map04910 | proguanil | 3242 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | proguanil | 3242 | drug-path |
| Focal adhesion | R-HSA-354113 | map04510 | proguanil | 3242 | drug-path |